---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-060794"
form_type: "8-K"
ticker: "AVIR"
cik: "0001593899"
company_name: "Atea Pharmaceuticals, Inc."
filed_at: "2025-03-24T23:59:59+00:00"
generated_at: "2026-05-24T06:33:24.630432+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Atea Pharmaceuticals receives director nominations from two stockholders for 2025 Annual Meeting

## Summary
- Bradley L. Radoff nominates Howard H. Berman, James P. Flynn, and Michael Torok.
- Driver Opportunity Partners III LP nominates J. Abbott R. Cooper for election.
- Nominating Committee will evaluate candidates; formal recommendation in proxy statement.
- No shareholder action required now; 2025 Annual Meeting date not yet scheduled.
- Evercore and Latham & Watkins retained as financial and legal advisors.

## SEC filing metadata
- accession: 0001193125-25-060794
- form_type: 8-K
- ticker: AVIR
- cik: 0001593899
- company_name: Atea Pharmaceuticals, Inc.
- filed_at: 2025-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/0001193125-25-060794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/d932774d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-060794
- JSON: https://secwatch.observer/filing/0001193125-25-060794.json
- Plain text: https://secwatch.observer/filing/0001193125-25-060794.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.